Phase II trial of bortezomib in combination with fractionated cyclophosphamide and rituximab (BCR) for relapsed/refractory mantle cell lymphoma (MCL) Meeting Abstract
| Authors: | Romaguera, J. E.; Fanale, M. A.; Samaniego, F.; Fayad, L. E.; Hagemeister, F. B.; McLaughlin, P.; Rodriguez, M. A.; Weaver, P.; Hartig, K.; Badillo, M.; Kwak, L. W.; Younes, A.; Pro, B.; Wang, M. |
| Abstract Title: | Phase II trial of bortezomib in combination with fractionated cyclophosphamide and rituximab (BCR) for relapsed/refractory mantle cell lymphoma (MCL) |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385008499 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.5122.5122 |
| Notes: | Meeting Abstract: 5122 -- Source: Wos |
